Substance / Medication

Nandrolone

Overview

Active Ingredient
nandrolone
RxNorm CUI
7244

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Association between nandrolone and behavioral alterations: A systematic review of preclinical studies.
Niromand Elham, Javanmardy Setareh, Salimi Zahra et al. · Steroids · 2021
PMID: 34407462Meta-Analysis
Nandrolone Decanoate: Use, Abuse and Side Effects.
Patanè Federico Giuseppe, Liberto Aldo, Maria Maglitto Andreana Nicoletta et al. · Medicina (Kaunas) · 2020
PMID: 33187340Meta-AnalysisFull text (PMC)
The impact of nandrolone decanoate on the central nervous system.
Busardò Francesco P, Frati Paola, Sanzo Mariantonia Di et al. · Curr Neuropharmacol · 2015
PMID: 26074747Meta-AnalysisFull text (PMC)
Illegal treatment of barrows with nandrolone ester: effect on growth, histology and residue levels in urine and hair.
Groot M J, Lasaroms J J P, van Bennekom E O et al. · Food Addit Contam Part A Chem Anal Control Expo Risk Assess · 2012
PMID: 22296620RCT
Influence of delivery mode on the urinary excretion of nandrolone metabolites.
Watson Phillip, Houghton Ed, Grace Philip B et al. · Med Sci Sports Exerc · 2010
PMID: 19952830RCT
Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease.
Eiam-Ong Somchai, Buranaosot Somphon, Eiam-Ong Somchit et al. · J Ren Nutr · 2007
PMID: 17462549RCT
Effects of protein-rich supplementation and nandrolone on bone tissue after a hip fracture.
Tengstrand Birgitta, Cederholm Tommy, Söderqvist Anita et al. · Clin Nutr · 2007
PMID: 17498850RCT
Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study.
Chung T, Kelleher S, Liu P Y et al. · Clin Endocrinol (Oxf) · 2007
PMID: 17223994RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Nandrolone (substance)
SNOMED CT
126171003
UMLS CUI
C0027368
RxNorm CUI
7244

Clinical Data

This intervention maps to 9 entities in the Ltrl knowledge graph.

2
Conditions
3
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.